Webinar: How to Get Great Place To Work-Certified™
MENU
Cabaletta Bio Inc

Cabaletta Bio Inc

Updated September 2020.

100%

Employees say this is a great place to work


Company Overview

About The Company

Cabaletta Bio is focused on the discovery and development of T cell therapies for patients with B cell-mediated autoimmune diseases. Cabaletta’s therapeutic platform produces highly selective autologous Chimeric AutoAntibody Receptor (CAAR) T cells that are designed to precisely bind and destroy only specific autoantibody-producing B cells while sparing normal antibody-producing B cells, which are essential for human health. Cabaletta Bio seeks to employ its specifically targeted CAAR (Chimeric AutoAntibody Receptor) T cell products to transform the lives of patients with autoimmune diseases by aiming to deliver deep and durable – potentially curative – responses.

COMPANY SIZE

31 U.S.-based Employees
(Small)

INDUSTRY

Biotechnology & Pharmaceuticals


Employee Demographics

Generation
Tenure

Company Culture at Cabaletta Bio Inc

The employee experience below at Cabaletta Bio Inc, compared to a typical company.

Learn More

100% of employees at Cabaletta Bio Inc say it is a great place to work compared to 57% of employees at a typical U.S.-based company.

  • Cabaletta Bio Inc
  • 100%
  • Typical Company
  • 57%
100%
Management is approachable, easy to talk with.
100%
People here are given a lot of responsibility.
100%
Management delivers on its promises.
100%
Management's actions match its words.
100%
I believe management would lay people off only as a last resort.

Why Work at Cabaletta Bio Inc?

See what employees say about what makes Cabaletta Bio Inc a great workplace. These words are drawn from employee comments on the Trust Index™ survey.


Best Workplaces Lists

Great Place To Work® is proud to recognize Cabaletta Bio Inc

Don't See Your Company Listed?

Nominate your company today to join Certification Nation

NOMINATE YOUR COMPANY